Attached files
file | filename |
---|---|
8-K - FORM 8-K - WATERS CORP /DE/ | b88676e8vk.htm |
Exhibit 99.1
For Immediate Release
Contact: Gene Cassis, Vice President of Investor Relations, 508-482-2349
Waters Corporation Reports Third Quarter 2011 Results
Milford, Massachusetts, October 25, 2011 Waters Corporation (NYSE/WAT) reported today third
quarter 2011 sales of $455 million, an increase of 13% over sales of $401 million in the third
quarter of 2010. These quarterly sales include 4% of foreign currency translation benefit. On a
GAAP basis, earnings per diluted share (E.P.S.) for the third quarter were $1.10 compared to $1.02
for the third quarter in 2010. On a non-GAAP basis, E.P.S. were up 16% to $1.14 in the third
quarter of 2011 from $0.98 in the third quarter of 2010. A reconciliation of GAAP to non-GAAP
E.P.S. is attached.
Through the first nine months of 2011, sales for the Company were $1,330 million, an increase of
15% in comparison to sales of $1,160 million in the first nine months of 2010. Foreign currency
translation contributed positively to sales growth during the first nine months of 2011 and
increased sales by 5%. E.P.S. for the first nine months of 2011 were $3.18 compared to $2.71 for
the comparable period in 2010. On a non-GAAP basis and including adjustments on the attached
reconciliation, E.P.S grew 20% in the first nine months of 2011 to $3.26 from $2.72 in 2010.
Commenting on the quarter, Douglas Berthiaume, Chairman, President and Chief Executive Officer
said, Our sales growth in the third quarter was driven by new instrument systems including
ACQUITY® H-Class UPLC®, UPLC-MS solutions and strong TA Instruments product
shipments. In addition, our growth was balanced geographically and across our key
customer groupings.
As communicated in a prior press release, Waters Corporation will webcast its third quarter 2011
financial results conference call this morning, October 25, 2011 at 8:30 a.m. eastern time. To
listen to the call, connect to www.waters.com, choose Investor and click on the Live Webcast. A
replay of the call will be available through November 1, 2011, similarly by webcast and also by
phone at 402-220-9741.
About Waters Corporation:
For over 50 years, Waters Corporation (NYSE/WAT) has created business advantages for
laboratory-dependent organizations by delivering practical and sustainable innovation to enable
significant advancements in such areas as healthcare delivery, environmental management, food
safety, and water quality worldwide.
Pioneering a connected portfolio of separations science, laboratory information management, mass
spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide
an enduring platform for customer success.
With revenue of $1.64 billion in 2010 and 5,400 employees, Waters is driving scientific discovery
and operational excellence for customers worldwide.
CAUTIONARY STATEMENT
This release may contain forward-looking statements regarding future results and events,
including statements regarding customer acceptance of our products, expansion of our business in
Asia and spending by certain end-markets that involve a number of risks and uncertainties. For this
purpose, any statements that are not statements of historical fact may be deemed forward-looking
statements. Without limiting the foregoing, the words, believes, anticipates, plans,
expects, intends, suggests, appears, estimates, projects, and similar expressions are
intended to identify forward-looking statements. The Companys actual future results may differ
significantly from the results discussed in the forward-looking statements within this release for
a variety of reasons, including and without limitation, the impact on demand among the Companys
various market sectors from economic, sovereign and political uncertainties; increased regulatory
burdens as the Companys business evolves, especially with respect to the U.S. Securities and
Exchange Commission, U.S. Food and Drug Administration, and U.S. Environmental Protection Agency,
among others; shifts in taxable income in jurisdictions with different effective tax rates; the
outcome of tax examinations or changes in respective country legislation affecting the Companys
effective tax rate; the ability to access capital and maintain liquidity in volatile financial
market conditions; fluctuations in capital expenditures by the Companys customers, in particular
large
pharmaceutical companies; the ability to sustain and enhance service and consumable demand from the
Companys installed base of instruments; regulatory and/or administrative obstacles to the timely
completion of purchase order documentation; introduction of competing products by other companies
and loss of market share; pressures on prices from competitors and/or customers; regulatory,
economic and competitive obstacles to new product introductions; other changes in demand from the
effect of mergers and acquisitions by the Companys customers; environmental and logistical
obstacles affecting the distribution of products; risks associated with lawsuits and other legal
actions, particularly involving claims for infringement of patents and other intellectual property
rights; the impact of changes in accounting principles and practices; and foreign exchange rate
fluctuations potentially affecting translation of the Companys future non-U.S. operating results.
Such factors and others are discussed more fully in the section entitled Risk Factors of the
Companys annual report on Form 10-K for the year ended December 31, 2010 and quarterly report on
Form 10-Q for the period ended July 2, 2011 as filed with the Securities and Exchange Commission,
which Risk Factors discussion is incorporated by reference in this release. The forward-looking
statements included in this release represent the Companys
estimates or views as of the date of
this release report and should not be relied upon as representing the Companys estimates or views
as of any date subsequent to the date of this release.
Waters Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands and unaudited)
Condensed Consolidated Balance Sheets
(In thousands and unaudited)
October 1, 2011 | December 31, 2010 | |||||||
Cash, cash equivalents and short-term investments |
1,194,217 | 946,419 | ||||||
Accounts receivable |
354,445 | 358,237 | ||||||
Inventories |
246,258 | 204,300 | ||||||
Other current assets |
68,439 | 77,685 | ||||||
Total current assets |
1,863,359 | 1,586,641 | ||||||
Property, plant and equipment, net |
221,059 | 215,060 | ||||||
Other assets |
555,197 | 525,969 | ||||||
Total assets |
2,639,615 | 2,327,670 | ||||||
Notes payable and debt |
271,578 | 66,055 | ||||||
Accounts payable and accrued expenses |
334,001 | 319,795 | ||||||
Total current liabilities |
605,579 | 385,850 | ||||||
Long-term debt |
700,000 | 700,000 | ||||||
Other long-term liabilities |
174,953 | 173,023 | ||||||
Total liabilities |
1,480,532 | 1,258,873 | ||||||
Total equity |
1,159,083 | 1,068,797 | ||||||
Total liabilities and equity |
2,639,615 | 2,327,670 |
Waters Corporation and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
(Unaudited) | (Unaudited) | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
October 1, 2011 | October 2, 2010 | October 1, 2011 | October 2, 2010 | |||||||||||||
Net sales |
$ | 454,534 | $ | 401,038 | $ | 1,329,764 | $ | 1,159,793 | ||||||||
Cost of sales |
180,318 | 162,985 | 526,250 | 464,050 | ||||||||||||
Gross profit |
274,216 | 238,053 | 803,514 | 695,743 | ||||||||||||
Selling and administrative expenses (1) (2) |
121,211 | 111,306 | 363,774 | 324,938 | ||||||||||||
Research and development expenses |
23,372 | 20,524 | 68,640 | 61,407 | ||||||||||||
Purchased intangibles amortization |
2,369 | 2,408 | 7,374 | 7,642 | ||||||||||||
Operating income |
127,264 | 103,815 | 363,726 | 301,756 | ||||||||||||
Interest expense, net |
(5,546 | ) | (3,294 | ) | (13,155 | ) | (8,752 | ) | ||||||||
Income from operations before income taxes |
121,718 | 100,521 | 350,571 | 293,004 | ||||||||||||
Provision for income taxes (3) |
20,461 | 5,802 | 54,750 | 37,845 | ||||||||||||
Net income |
$ | 101,257 | $ | 94,719 | $ | 295,821 | $ | 255,159 | ||||||||
Net income per basic common share |
$ | 1.12 | $ | 1.03 | $ | 3.24 | $ | 2.75 | ||||||||
Weighted-average number of basic common shares |
90,688 | 91,714 | 91,334 | 92,647 | ||||||||||||
Net income per diluted common share |
$ | 1.10 | $ | 1.02 | $ | 3.18 | $ | 2.71 | ||||||||
Weighted-average number of diluted common shares and equivalents |
92,060 | 93,286 | 92,898 | 94,271 |
(1) | Included in selling and administrative expenses for the three and nine months ended October 1, 2011 are costs of $3 million and $5 million, respectively, related to cost reduction plans, asset impairments related to certain Company facilities and acquisition costs related to a recent acquisition. | |
Included in selling and administrative expenses for the three and nine months ended October 2, 2010 are costs of $1 million and $3 million, respectively, related to cost reduction plans and asset impairments related to certain Company facilities. |
(2) | Included in selling and administrative expenses for both the three and nine months ended October 2, 2010 are costs of $3 million associated with a non-income tax audit settlement. | |
(3) | Included in the provision for income taxes for the nine months ended October 1, 2011 is a tax benefit of $2 million related to the settlement of an audit. Included in the provision for income taxes for both the three and nine months ended October 2, 2010 is a net tax beneift of $8 million related to the reversal of a reserve for an uncertain tax position due to an audit settlement. Included in the provision for income taxes for the nine months ended October 2, 2010 is a tax benefit of $2 million related to the resolution of a pre-acquisition tax exposure. |
Waters Corporation and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
(Unaudited) | (Unaudited) | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
October 1, 2011 | October 2, 2010 | October 1, 2011 | October 2, 2010 | |||||||||||||
Reconciliation of net income per diluted share, in accordance with
generally accepted accounting principles, with adjusted results: |
||||||||||||||||
Net income per diluted share |
$ | 1.10 | $ | 1.02 | $ | 3.18 | $ | 2.71 | ||||||||
Adjustment for purchased intangibles amortization, net of tax |
1,693 | 1,727 | 5,271 | 5,512 | ||||||||||||
Net income per diluted share effect |
0.02 | 0.02 | 0.06 | 0.06 | ||||||||||||
Adjustment for restructuring costs, asset impairments and
acquisition-related costs, net of tax |
1,856 | 366 | 3,223 | 2,210 | ||||||||||||
Net income per diluted share effect |
0.02 | 0.00 | 0.03 | 0.02 | ||||||||||||
Adjustment for one-time tax benefits |
| | (1,617 | ) | (1,500 | ) | ||||||||||
Net income per diluted share effect |
| | (0.02 | ) | (0.02 | ) | ||||||||||
Adjustment for reversal of income tax reserves upon audit settlement |
| (7,581 | ) | | (7,581 | ) | ||||||||||
Net income per diluted share effect |
| (0.08 | ) | | (0.08 | ) | ||||||||||
Adjustment for non-income tax audit settlement, net of tax |
| 2,197 | | 2,197 | ||||||||||||
Net income per diluted share effect |
| 0.02 | | 0.02 | ||||||||||||
Adjusted net income per diluted share |
$ | 1.14 | $ | 0.98 | $ | 3.26 | $ | 2.72 | ||||||||
The adjusted net income per diluted share presented above is used by the management of the
Company to measure operating performance with prior periods and is not in accordance with generally
accepted accounting principles (GAAP). The above reconciliation identifies items management has
excluded as non-operational transactions, net of the effective applicable statutory tax rates.
Management has excluded the purchased intangibles amortization, restructuring costs, asset
impairments, acquisition-related costs, one-time tax benefits, reversal of income tax reserves upon
audit settlement and non-income tax audit settlement from its non-GAAP adjusted amounts since
management believes that these items are not directly related to ongoing operations, thereby
providing management and investors with information that may help them to compare ongoing operating
performance.